ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 754329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 754329; 2) Community: the network communities that were significantly associated with the response to NSC 754329; 3) Molecule: the relationships between components within communities and NSC 754329; 4) MDR: the compounds that were significantly associated with the NSC 754329.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.0385203205529759 0.086514558
NSC 129518 Cyclopyrethrosin 0.0385203205529759 0.3226187
NSC 144310 4H-Thiopyran-4-one, 3,5-bis[(3,4-dimethoxyphenyl) methylene]-tetrahydro- 0.0385203205529759 0.4848316
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0385203205529759 0.4118567
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0385203205529759 0.53849634
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.0385203205529759 0.37755709
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0385203205529759 0.41199609
NSC 302991 Camptothecin Derivative 0.0385203205529759 0.12471854
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0385203205529759 0.42214826
NSC 328785 ANTINEOPLASTIC-328785 0.0385203205529759 0.38823061
Total:87  Current:68    [First] [Prev] [Next] [Last]